Morgan Stanley underweight on Sun Pharma; SPARC#39;s Baclofen GRS fails in phase III study News News / News 7 years ago 726 Views comments Sun Pharma is a manufacturing/marketing partner of SPARC on a product-by-product merit-based selection process. Read more
News Huge opportunity in EV space; will produce 250,000 vehicles next year: OK Play India News / News - 7 years ago
News What are fund managers saying about the RBI#39;s bi-monthly monetary policy News / News - 7 years ago
Comments